$26/sh. is still less than $1Bil market cap (around $935 mil.). Plus over $100 mil. cash and hundreds of millions in old tax losses. Omontys alone should sell in the billion(s).
'Omontys alone should sell in the billion(s).'
Well, that's lucky because that's all there is. Affy is a great company with a great drug but there is nothing else.
Where do you guys come from?